Patent · US Active

Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

US9505782B2 · kind B2 · utility

19Cited by
3References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2015
Grant dateNov 29, 2016
Priority date
Expiry dateNov 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to thienopyrimidine and thienopyridine compounds and methods of use thereof. In particular embodiments, the present disclosure provides compositions comprising thienopyrimidine and thienopyridine compounds of Formula 2:and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.